Sullivan & Cromwell advised Ally Financial, while Orrick represented the underwriters in the offerings. Ally Financial, a leader in digital financial services, has closed on two...
You must be a Standard 1 Year member to access this content.
Orrick represented Kineta on the deal. Kineta, Inc., a clinical-stage biotechnology company focused on developing novel immunotherapies in oncology that address cancer immune resistance, has entered...
You must be a Standard 1 Year member to access this content.
Orrick advised Catalyst Biosciences, Inc. on the deal. South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. announced its acquisition of the F351 program, a next-generation fibrosis drug,...
You must be a Standard 1 Year member to access this content.
